Video

Angela Fishbaugh on Discovering Your Story and Skills

Author(s):

Angela Fishbaugh
Conference|FORCE Conference

Angela Fishbaugh, author of "Angela's Decision," discusses how to discover your skills and story within.

Angela Fishbaugh, previvor and survivor, author of Angela's Decision, discusses how survivors can get in tune with their own gifts and skills to help them tell the story inside of them.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of smiling doctor.
Top 3 Takeaways From ASCO GU 2025
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Emphasizing the Importance of Breast Cancer Education and Screenings
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
The Power of Knowledge and Staying Informed in Breast Cancer Care
Image of woman with blonde hair.
Targeted Axillary Dissection Offers a Precise Option in Breast Cancer
Image of woman with blonde hair.
Guiding Patients Through Shared Decision-Making in Breast Cancer Care
Image of woman with brown hair.
Understanding the Best Practices Associated With CDK4/6 Therapy in Breast Cancer
Image of doctor with brown hair.
COSMIC-313 Trial Lead Breaks Down Treatment Intensification in RCC
Image of Doctor with blonde hair.
Krazati and Erbitux Combo Benefits KRAS G12C+ Metastatic Colorectal Cancer
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
An Expert Explains The Risk and Outcomes of Primary Urothelial Cancer Treatment
Image of bald man.
An Expert Explains Updated Data For Patients With GU Cancers
Related Content
Image of man holding stomach.
April 6th 2025

FDA Grants HLX22 Orphan Drug Designation for Gastric Cancer

Spencer Feldman
FDA grants orphan drug designation to HLX22 for gastric cancer, with a phase 2 trial showing improved progression-free survival and objective response.
cancer horizons image for podcast
December 14th 2023

Conference Highlights from the 2023 ASH Annual Meeting

Brielle Benyon Alex Biese
CURE® recently covered the 2023 American Society of Hematology Annual Meeting. In case you missed it, here is some news that came out of the conference that patients should know about.
Illustratoin of lungs
April 2nd 2025

Camrelizumab Combo Doubles 5-Year Survival in Phase 3 Lung Cancer Trial

Spencer Feldman
Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a Phase 3 trial.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Image of lung.
March 31st 2025

COCOON Trial Regimen Reduces Dermatologic Side Effects in Mutated Lung Cancer

Spencer Feldman
The COCOON trial regimen reduced dermatologic side effects in patients with EGFR-mutant non-small cell lung cancer, phase 2 trial data showed.
Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in EGFR+ advanced or metastatic NSCLC: © SciePro - stock.adobe.com
March 31st 2025

First-line Rybrevant Combo Extends Survival in Advanced Lung Cancer

Ryan Scott
First-line Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in mutated, advanced or metastatic non-small cell lung cancer.